Compare PLYX & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLYX | SKIN |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.1M | 123.9M |
| IPO Year | N/A | 2020 |
| Metric | PLYX | SKIN |
|---|---|---|
| Price | $2.89 | $1.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $2.00 |
| AVG Volume (30 Days) | ★ 3.1M | 659.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.63 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $334,294,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.20 | $0.78 |
| 52 Week High | $8.15 | $2.69 |
| Indicator | PLYX | SKIN |
|---|---|---|
| Relative Strength Index (RSI) | 30.62 | 42.26 |
| Support Level | $2.26 | $0.87 |
| Resistance Level | $3.20 | $1.69 |
| Average True Range (ATR) | 0.70 | 0.09 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 24.20 | 64.38 |
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.